POMACIN Trademark

Trademark Overview


On Thursday, December 30, 2010, a trademark application was filed for POMACIN with the United States Patent and Trademark Office. The USPTO has given the POMACIN trademark a serial number of 85207993. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2012. This trademark is owned by Pfizer Inc.. The POMACIN trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflamma...
pomacin

General Information


Serial Number85207993
Word MarkPOMACIN
Filing DateThursday, December 30, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements


Goods and ServicesVeterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals, anthelmintics, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, January 30, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2011ASSIGNED TO EXAMINER
Friday, January 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 3, 2011NEW APPLICATION ENTERED IN TRAM